1Bos LJ, Damen EM, de Boer RW, et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation [ J ]. Int J Radiat Oncol Biol Phys, 2002, 52 ( 1 ) : 254 - 265.
3Studer G, Huguenin PU, Davis JB, et al. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients I ]. Radiat Oncol, 2006, 1 : 7.
4Schwartz M, Vuong T, Ballivy O, et al. Accelerated ra- diotherapy with simultaneous integrated boost fractionation and intensity-modulated radiotherapy for advanced head and neck cancer [ J]. Otolaryngol Head Neck Surg, 2007, 136 (4):549-555.
2Abelson JA,Murphy JD,Trakul N. Metabolic im-aging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy[J].{H}Lung Cancer,2012,(03):219-224.
3Harada H,Nishio M,Murakami H. Dose-escalation study of three-dimensional conformal thoracic radio-therapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer[J].Clin Lung Cancer,2013,(04):440-445.
4Yee D,Butts C,Reiman A. Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer[J].Radio-ther Oncol,2012,(02):234-238.
5Hirose T,Nakashima M,Shirai T. Phase II trial of amrubicin and carboplatin in patients with sensitive or re-fractory relapsed small-cell lung cancer[J].{H}Lung Cancer,2011,(03):345-350.
6Demkow U,Anna SE. Cardiotoxicity of cisplatin-based chemotherapy in advanced non-small cell lung cancer pa-tients[J].{H}Respiratory Physiology & Neurobiology,2013,(01):64-67.
7James W, Palmer MB, Ajani JA, et al. Esophageal cancer dose es- calation using a simultaneous integrated boost technique[J]. Inter- national Journal of Radiation Oncology Biology & Physics, 2012, 82(1): 468-474.
